Solving doubts about L‐ornithine L‐aspartate for overt hepatic encephalopathy: Whom and how to treat

E-ISSN： 1527-3350|67|2|476-478

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.67, Iss.2, 2018-02, pp. : 476-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 700-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Terminating and episode of overt hepatic encephalopathy: L‐ornithine‐L‐aspartate may have some role

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 797-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

LOLA in minimal hepatic encephalopathy

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 956-963

John Wiley & Sons Inc

Access to resources Recommend Favorite

L’aspartate

By Gouzy Alexandre Poquet Yannick Neyrolles Olivier

Médecine/sciences, Vol. 30, Iss. 3, 2014-03 ,pp. : 242-244

Edp Sciences

Access to resources Recommend Favorite

L-Ornithine Apartate – a Rationale for Its Use in Combination with Chemotherapy, Radiation, and Hyperthermia in Oncology

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 6, Iss. 4, 2004-11 ,pp. : 216-216

Karger

Access to resources Recommend Favorite